RIBON THERAPEUTICS INC has a total of 32 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are GOLDFINCH BIO INC, ONCOTARTIS INC and ARTIOS PHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Taiwan | 2 | |
#10 | Chile | 1 | |
#11 | China | 1 | |
#12 | Colombia | 1 | |
#13 | Ecuador | 1 | |
#14 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Vasbinder Melissa Marie | 28 |
#2 | Schenkel Laurie B | 28 |
#3 | Kuntz Kevin Wayne | 28 |
#4 | Swinger Kerren Kalai | 26 |
#5 | Wigle Timothy J N | 3 |
#6 | Kevin Wayne Kuntz | 2 |
#7 | Laurie B Schenkel | 2 |
#8 | Melissa Marie Vasbinder | 2 |
#9 | Blackwell Danielle J | 2 |
#10 | Downing Jennifer | 2 |
Publication | Filing date | Title |
---|---|---|
US2021032251A1 | Heterobicyclic amides as inhibitors of cd38 | |
WO2020257416A1 | Targeted protein degradation of parp14 for use in therapy | |
WO2020223229A1 | Solid forms of a parp7 inhibitor | |
TW202014416A | Pyridazinones as parp7 inhibitors | |
WO2019212946A1 | Screening methods for parp modulators | |
WO2019126443A1 | Quinazolinones as parp14 inhibitors |